Table 10. Weighted arithmetic mean, minimum and maximum proportion of resistance (%R or %R + I) and weighted standard deviation (SD) in Streptococcus dysgalactiae for the target antimicrobials in each continent. NA means that SD could not be calculated as only one study was included
| Antibiotic | Continent | No. of papers | No. of isolates | Weighted arithmetic mean proportion of resistance (%) | Minimum resistance % observed | Maximum resistance % observed | Standard deviation |
|---|---|---|---|---|---|---|---|
| 3GC (Cefoperazone) | Europe | 1 | 213 | 4.2 | 4.2 | 4.2 | NA |
| 3GC (Ceftiofur) | North America | 2 | 414 | 0 | 0 | 0 | 0 |
| Erythromycin | Asia | 1 | 88 | 47.7 | 47.7 | 47.7 | NA |
| Erythromycin | Europe | 4 | 422 | 11.5 | 4.9 | 22 | 6.2 |
| Erythromycin | Oceania | 1 | 349 | 16.3 | 16.3 | 16.3 | NA |
| Fluoroquinolones | Asia | 1 | 14 | 7.1 | 7.1 | 7.1 | NA |
| Fluoroquinolones | Europe | 4 | 410 | 22.4 | 3.7 | 47 | 21 |
| Penicillin | Asia | 1 | 14 | 7.1 | 7.1 | 7.1 | NA |
| Penicillin | Europe | 5 | 321 | 4.6 | 0 | 7 | 3.3 |
| Penicillin | Oceania | 2 | 1,106 | 2.3 | 0 | 2.4 | 0.6 |
| Penicillin–novobiocin | North America | 1 | 317 | 0.3 | 0.3 | 0.3 | NA |
| Pirlimycin | North America | 1 | 317 | 7.9 | 7.9 | 7.9 | NA |
| Spiramycin | Europe | 3 | 579 | 19 | 4.3 | 39.9 | 16 |
| Sulfa/TMP | Asia | 1 | 14 | 14.3 | 14.3 | 14.3 | NA |
| Sulfa/TMP | Europe | 4 | 393 | 7.4 | 0 | 15 | 7 |
| Sulfa/TMP | North America | 1 | 317 | 0.3 | 0.3 | 0.3 | NA |
| Sulfa/TMP | Oceania | 1 | 64 | 17.2 | 17.2 | 17.2 | NA |
| Tylosin | Europe | 2 | 158 | 13.7 | 11.1 | 14 | 0.9 |